Clinical Trial Update: Atacicept in Subjects With Active Lupus Nephritis (COMPASS) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating atacicept in active lupus nephritis has been withdrawn (COMPASS), with no results reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• Atacicept (atacicept)

Snippet

Sponsor: Vera Therapeutics, Inc. | Conditions: Lupus Nephritis (LN) | Phase 3 | Status: WITHDRAWN